Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2014 Oct 20;111(44):15851. doi: 10.1073/pnas.1419043111

Retraction for Nandakumar et al., Dominant suppression of inflammation by glycan-hydrolyzed IgG

PMCID: PMC4226091  PMID: 25331904

MEDICAL SCIENCES Retraction for “Dominant suppression of inflammation by glycan-hydrolyzed IgG,” by Kutty Selva Nandakumar, Mattias Collin, Kaisa E. Happonen, Allyson M. Croxford, Susanna L. Lundström, Roman A. Zubarev, Merrill J. Rowley, Anna M. Blom, and Rikard Holmdahl, which appeared in issue 25, June 18, 2013, of Proc Natl Acad Sci USA (110:10252–10257; first published May 13, 2013; 10.1073/pnas.1301480110).

The authors wish to note the following: “Using studies of IgG hydrolyzed by the streptococcal glycan hydrolyzing enzyme EndoS, we found that treatment of mice with hydrolyzed IgG blocked antibody mediated arthritis. As an explanation for this observation, we suggested that EndoS-hydrolyzed IgG per se dominantly blocks local immune complex formation.

“With new data from our own follow up experiments, we have now found that this conclusion was incorrect.

“Our new data shows that injection of EndoS is much more potent in vivo than we could logically anticipate, as i.v. injection of doses containing less than 0.1 µg EndoS mixed with IgG suppressed arthritis using the same model as the one reported in the initial paper (collagen antibody-induced arthritis). We previously excluded the possibility that contaminating EndoS could play a role, as this contaminating amount was not detected using standard methods in the hydrolyzed IgG fraction we used in the experiments. Furthermore, much higher doses of EndoS injected in the same mouse strain as a control experiment did not affect collagen induced arthritis in earlier experiments. The correct interpretation of our collective data is that EndoS operates very potently in vivo on an immune complex-mediated disease, possibly by accumulating within immune complexes. Because this interpretation is different from our major conclusion of the published paper, the authors have unanimously decided to retract this paper to be able to publish the data connected with a correct interpretation. We sincerely apologize to readers of this paper, who might have been misled by our earlier interpretation.”

Kutty Selva Nandakumar

Mattias Collin

Kaisa E. Happonen

Allyson M. Croxford

Susanna L. Lundström

Roman A. Zubarev

Merrill J. Rowley

Anna M. Blom

Rikard Holmdahl


Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES